Automated One Step Solid Phase Extraction and Concentration of PCBs in Water
The Application Notebook
PCBs are a group of synthetic organic chemicals that contain 209 individual compounds (known as congeners) with varying harmful effects. PCBs enter the environment as mixtures containing a variety of individual components.
PCBs are a group of synthetic organic chemicals that contain 209 individual compounds (known as congeners) with varying harmful effects. PCBs enter the environment as mixtures containing a variety of individual components. PCBs have been widely used as coolants and lubricants in transformers, capacitors, and other electrical equipment. The manufacture of PCBs stopped due to evidence that PCBs build up in the environment and cause harmful effects. Due their extreme toxicity, durability, and wide industrial use, PCBs have found their way into drinking water supplies. The PowerPrep SPE and PowerVap Direct to Vial Concentration system speeds up the sample prep process for the analysis of PCBs by combining these sample prep steps into one.
Table I: Results
Instrumentation
- FMS, Inc. Power Prep SPE (solid phase extraction) system
- Waters Oasis 1 g HLB SPE cartridge
- FMS, Inc. PowerVap Concentrator
- Thermo Fisher Scientific Polaris Q GCMS
Method Summary
PowerPrep SPE
1. Condition Cartridge: 10 mL MeOH
2. Condition Cartridge: 10 mL H2O
3. Load Sample: 15 min
4. Rinse bottle: 5 s
5. Load rinse: 1 min
6. Dry Cartridge: 30 min
7. Elute Sample: 20 mL DCM
PowerVap Concentrator
1. Pre-heat temp: 55 °C
2. Pre-heat time: 30 min
3. Heat in Sensor mode: 65 °C
4. Nitrogen Pressure: 15 PSI
Figure 1: Results of PCB congeners in sample extract.
Procedure
Five 1 L water samples were each spiked with a mixture of 19 individual PCB congeners at 1 ug/mL each. Samples were also spiked with a 1 ug/mL tetrachloro-m-xylene solution as an extraction surrogate. Using the Power Prep SPE system, samples were then loaded on prewet Oasis HLB cartridges using vacuum to draw the samples across the cartridge. Sample bottles were automatically rinsed. Cartridges were dried using a nitrogen stream blown across the cartridge to remove all remaining water. Once dried, the cartridges were eluted with 20 mLs of DCM directly to the FMS PowerVap Concentrator into direct to vial tubes. Extracts were blown down to a 1 mL final volume using the FMS direct to vial concentrator tubes. Extracts were then transferred for GC–MS analysis.
Conclusions
The FMS PowerPrep SPE and PowerVap perform Automated One Step and Direct to Vial Concentration. Combining sample prep processes is shown to efficiently extract PCB samples at a high rate of speed producing excellent recoveries and reproducibility for water samples. The combination of the FMS PowerPrep SPE system and the Waters Oasis HLB cartridge demonstrates consistent, reproducible, reliable high throughput automated sample extraction of PCBs.
FMS, Inc.
580 Pleasant Street Watertown, MA 02472
tel. (617) 393-2396, fax: (617) 393-0194
Email: onlineinfo@fms-inc.com
Website: www.fmsenvironmental.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
